Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice

被引:148
作者
Cole, J
Ertoy, D
Lin, HC
Sutliff, RL
Ezan, E
Guyene, TT
Capecchi, M
Corvol, P
Bernstein, KE
机构
[1] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA
[2] Coll France, INSERM, U36, F-75231 Paris, France
[3] Univ Utah, Eccles Inst Human Genet, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA
关键词
D O I
10.1172/JCI10557
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
While nephrologists often observe reduced hematocrit associated with inhibitors of angiotensin-converting enzyme (ACE), the basis for this effect is not well understood. We now report that two strains of ACE knockout mice have a normocytic anemia associated with elevated plasma erythropoietin levels. Cr-51 labeling of red cells showed that the knockout mice have a normal total blood volume but a reduced red cell mass. ACE knockout mice, which lack tissue ACE, are anemic despite having normal renal function. These mice have increased plasma levels of the peptide acetyl-SDKP, a possible stem cell suppressor. However, they also show low plasma levels of angiotensin II. Infusion of angiotensin II for 2 weeks increased hematocrit to near normal levels. These data suggest that angiotensin II facilitates erythropoiesis, a conclusion with implications for the management of chronically ill patients on inhibitors of the renin-angiotensin system.
引用
收藏
页码:1391 / 1398
页数:8
相关论文
共 34 条
[1]
High dose enalapril impairs the response to erythropoietin treatment in haemodialysis patients [J].
Albitar, S ;
Genin, R ;
Fen-Chong, M ;
Serveaux, MO ;
Bourgeon, B .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (05) :1206-1210
[2]
Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline [J].
Azizi, M ;
Rousseau, A ;
Ezan, E ;
Guyene, TT ;
Michelet, S ;
Grognet, JM ;
Lenfant, M ;
Corvol, P ;
Menard, J .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (03) :839-844
[3]
BERNSTEIN SELDON E., 1966, P337
[4]
BHAT GJ, 1994, J BIOL CHEM, V269, P31443
[5]
BONNET D, 1993, BLOOD, V82, P3307
[6]
Effect of angiotensin-converting enzyme inhibitors on response to erythropoietin therapy in chronic dialysis patients [J].
Charytan, C ;
Goldfarb-Rumyantzev, A ;
Wang, YF ;
Schwenk, MH ;
Spinowitz, BS .
AMERICAN JOURNAL OF NEPHROLOGY, 1998, 18 (06) :498-503
[7]
The effect of angiotensin II receptor antagonist on the exogenous erythropoietin requirement of haemodialysis patients [J].
Chew, CG ;
Meise, MD ;
Disney, APS .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (08) :2047-2049
[8]
CONLON PJ, 1993, TRANSPLANTATION, V56, P217
[9]
CORVOL P, 1995, METHOD ENZYMOL, V248, P283
[10]
Angiotensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: Any evidence of erythropoietin resistance? [J].
Cruz, DN ;
Perazella, MA ;
AbuAlfa, AK ;
Mahnensmith, RL .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (04) :535-540